Reuters logo
Smith & Nephew to buy U.S. wound care business for $782 mln
November 28, 2012 / 7:31 AM / 5 years ago

Smith & Nephew to buy U.S. wound care business for $782 mln

LONDON, Nov 28 (Reuters) - Artificial hip and knee maker Smith & Nephew said it was expanding in the fast-growing area of bioactive wound care by acquiring privately-held U.S. firm Healthpoint.

S&N said it would pay $782 million in cash for the company, which makes Santyl, an ointment for the removal of dead tissue in wounds, and is in phase III trials for a treatment for leg ulcers.

Healthpoint had $190 million revenues in 2012 and S&N expects the deal to be accretive to earnings from 2013, it said on Wednesday.

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below